Direct-to-consumer genomics on the scales of autonomy
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Personal utility is inherent to direct-to-consumer genomic testing
- Privacy, autonomy and direct-to-consumer genetic testing: a response to Vayena
- Do genomic tests enhance autonomy?
- Personal utility in genomic testing: is there such a thing?
- On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
- Regulating the advertising of genetic tests in Europe: a balancing act
- From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?
- Commercial DNA tests and police investigations: a broad bioethical perspective
- Knowing me, knowing you
- Sport and exercise genomics: the FIMS 2019 consensus statement update